Back
Corvus Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
CRVS
Corvus Pharmaceuticals, Inc.
Last Price:
$19.03
Seasonality Move:
-12.7%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corvus Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.3 | Sell |
| 20-day SMA: | 19.29 | Buy |
| 50-day SMA: | 12.43 | Buy |
| 200-day SMA: | 7.15 | Buy |
| 8-day EMA: | 18.47 | Buy |
| 20-day EMA: | 12.82 | Buy |
| 50-day EMA: | 6.71 | Buy |
| 200-day EMA: | 1.94 | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.49 | Buy |
| Relative Strength Index (14 RSI): | 60.57 | Buy |
| Chaikin Money Flow: | 1595904 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.93 - 23.67) | Buy |
| Bollinger Bands (100): | (4.65 - 15.23) | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals, Inc. Stock
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 19.74 while CRVS 8-day simple moving average is 20.30, which is a Sell signal.
-
The stock price of CRVS is 19.74 while Corvus Pharmaceuticals, Inc. 20-day SMA is 19.29, which makes it a Buy.
-
Corvus Pharmaceuticals, Inc. 50-day simple moving average is 12.43 while CRVS share price is 19.74, making it a Buy technically.
-
CRVS stock price is 19.74 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 7.15, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Buy
60
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Is Corvus Pharmaceuticals, Inc. a Buy or a Sell?
-
Corvus Pharmaceuticals, Inc. stock is rated a BuyThe current Corvus Pharmaceuticals, Inc. [CRVS] share price is $19.74. The Score for CRVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Corvus Pharmaceuticals, Inc. Stock Info
Market Cap:
1.5B
Price in USD:
19.74
Share Volume:
1.7M
Corvus Pharmaceuticals, Inc. 52-Week Range
52-Week High:
26.95
52-Week Low:
2.54
Buy
60
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Corvus Pharmaceuticals, Inc. Share Price Forecast
-
What is the Corvus Pharmaceuticals, Inc. stock price today?The Corvus Pharmaceuticals, Inc. stock price is 19.74 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals, Inc. is not overvalued.
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 19.74 while CRVS 8-day exponential moving average is 18.47, which is a Buy signal.
-
The stock price of CRVS is 19.74 while Corvus Pharmaceuticals, Inc. 20-day EMA is 12.82, which makes it a Buy.
-
Corvus Pharmaceuticals, Inc. 50-day exponential moving average is 6.71 while CRVS share price is 19.74, making it a Buy technically.
-
CRVS stock price is 19.74 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 1.94, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals, Inc.
Is Corvus Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.44 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Corvus Pharmaceuticals, Inc.
Should I short Corvus Pharmaceuticals, Inc. stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is 5.49, suggesting Corvus Pharmaceuticals, Inc. is a Buy
-
Corvus Pharmaceuticals, Inc. Relative Strength Index (RSI) is 60.57, which suggest Corvus Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Corvus Pharmaceuticals, Inc. is (9.93 - 23.67), which suggest Corvus Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Corvus Pharmaceuticals, Inc. is (4.65 - 15.23), which suggest Corvus Pharmaceuticals, Inc. is a Buy
* Corvus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.